Old Web
English
Sign In
Acemap
>
authorDetail
>
Takahiko Murata
Takahiko Murata
Medicine
Immunology
Agonist
Internal medicine
Molecular biology
5
Papers
20
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
KAG-308, a newly-identified EP4-selective agonist shows efficacy for treating ulcerative colitis and can bring about lower risk of colorectal carcinogenesis by oral administration
2015
European Journal of Pharmacology
Yusuke Watanabe
Takahiko Murata
Masahiro Amakawa
Yoshihide Miyake
Tango Handa
Katsuhiko Konishi
Yasushi Matsumura
Takuji Tanaka
Koji Takeuchi
Show All
Source
Cite
Save
Citations (19)
Kag-308, a Novel Orally Active EP4 Agonist, Ameliorates Mucosal Injury on Endoscopic Examination in a Chronic Colitis Model
2011
Gastroenterology
Tango Handa
Masahiro Amakawa
Yoshihide Miyake
Mihoko Takami
Takahiko Murata
Katsuhiko Konishi
Yasushi Matsumura
Show All
Source
Cite
Save
Citations (0)
Effects of KP-496, a Novel Dual Antagonist for Cysteinyl Leukotriene Receptor (CysLT1R) and Thromboxane A2 Receptor (TP), on Porcine Pancreas Elastase Induced Emphysema in Mice
2007
The Journal of Allergy and Clinical Immunology
Shigeo Kurokawa
Toshiaki Okuda
M. Amakawa
M. Suda
Takahiko Murata
Y Hiyama
Show All
Source
Cite
Save
Citations (1)
Agent préventif ou thérapeutique pour les maladies inflammatoires chroniques des poumons
2005
Toshiaki Okuda
Shigeo Kurokawa
Takahiko Murata
M. Amakawa
Ts Nakamura
Show All
Source
Cite
Save
Citations (0)
Medicaments protegeant les nerfs
2000
Takahiko Murata
Tadashi Ohyama
Masahiro Amakawa
Keiko Fujita
Haruyoshi Ueo
Show All
Source
Cite
Save
Citations (0)
1